The Strategic Role of IP in Corporate M&A

While the likes of Mark Cuban typically complain about the problems with Intellectual Property, particular when it comes to the software industry, even he will admit the strategic importance of patents, trademarks and copyrights when it comes to “doing deals.” Some examples of very recent vintage ring a bell, including the smartphone patent wars involving Microsoft, Google, Samsung and Apple.

Even trademarks have particular significance. In light of the recent union debacle with Hostess and “Twinkies” we’ve seen the importance of branding and trademarks in strategic corporate decision making. The following quote outlines IP’s importance in a simple one-liner:

If this business were split up, I would give you the land and bricks and mortar, and I would take the brands and trade marks, and I would fare better than you.

— John Stuart, Chairman of Quaker (ca. 1900)

Why IP Sits at the Heart of M&A Strategy

Intellectual property is rarely a side consideration in a merger or acquisition — it is often the core strategic asset being transacted. Whether a buyer seeks to expand into a new market segment, block a competitor, or accelerate a product roadmap, the IP portfolio of a target company can be the decisive variable. Advisors conducting due diligence on a potential acquisition should treat IP schedules with the same rigor applied to financial statements.

There are three primary categories of IP that surface in corporate transactions: patents, trademarks, and copyrights (with trade secrets occupying a closely related fourth category). Each carries distinct valuation mechanics, transferability rules, and risk profiles. A patent that is central to a target’s product architecture may require an independent IP counsel opinion on validity and infringement exposure before any offer letter is signed.

IP Can Represent Years of Investment

Admittedly, patent squatters exist to extract value out of a seemingly flawed system. However, there are other reasons IP exists. Some would use a blanket statement approach, claiming “patents protect the little guy.” I would argue that the true benefit of the legal system when it comes to IP is to protect investment. Capital, human and time resources are all components of establishing value-added intellectual property.

Without patent law in place, idea, trademark and source-code thievery would abound with no real consequences to the perpetrator. Think of the previous Twinkie example of a trademarked brand with years of brand investment behind it. Millions of dollars have been spent on brand, distribution, product and company building since Twinkie was established as a brand in 1930.

Apollo Global Management LLC is obviously seeing they may be able to invest years of goodwill and brand equity by obtaining Twinkie’s brand and trademarks on the cheap and out of bankruptcy. IP can and does protect the little guy, but the truth is that a large majority of patents, trademarks and copyrights are owned by the corporate-world equivalent of the 1%.

That said, when smaller corporations practice creative destruction through the genesis of new ideas, there remains a value-add for larger strategic acquirers.

IP Due Diligence: What Buyers Actually Examine

In a thorough M&A due diligence process, buyers and their counsel typically work through an IP schedule that covers several key areas:

• Ownership verification. Does the company actually own the IP it claims to own, or do prior employees, contractors, or academic institutions hold residual rights?
• Registration status. Are patents, trademarks, and domain names properly registered and maintained? Lapsed maintenance fees can invalidate patents without warning.
• Encumbrances and licenses. Are there exclusive licenses granted to third parties that would survive the transaction and limit the buyer’s freedom to operate?
• Infringement risk. Is there pending or threatened litigation from competitors claiming the target’s products infringe third-party patents?
• Trade secret hygiene. Does the company have documented policies and access controls protecting proprietary processes, formulas, and source code?

Buyers who skip or compress IP diligence sometimes discover post-close that a critical product feature is encumbered by a license that requires royalty payments to a former partner — a material reduction in the value of what they acquired.

Acquisitions: More than Just “Goodwill”

In spite of some of the ridiculously large “goodwill” write-downs we’ve seen in recent M&A transactions, much remains to be gleaned from the value such goodwill has provided larger firms seeking to enter new markets with a winning strategy. Take the semi-recent $1 billion acquisition of Seattle-based Isilon Systems by EMC. Many claimed there was massive over-payment on EMC’s part for the assets and goodwill of Isilon.

However, EMC was able to recoup the Isilon acquisition in short order as demand for “big data” coupled with EMC’s existing and massive sales force provided a channel to which Isilon’s technology could be funneled. It was a strategic move on the part of EMC — a highly-calculated acquisition of goodwill that ultimately paid off. Not all goodwill acquisitions have such astounding results.

Does the aQuantive deal by Microsoft ring any bells? However, as long as there is IP law, patent wars and massive goodwill M&A will abound.

How IP Shapes Deal Valuation

For a strategic acquirer, the IP portfolio often justifies a premium above what a pure financial buyer would offer. When an acquirer’s internal team would require years of R&D investment to replicate a competitor’s patent-protected product features, acquiring that portfolio through a transaction can represent a genuine shortcut. This dynamic drives many of the outsized multiples seen in technology, pharmaceutical, and consumer-brand M&A.

Financial buyers — particularly private equity firms — tend to be more conservative in ascribing standalone value to IP that is not directly tied to revenue-generating products. They will, however, scrutinize IP as a risk management exercise, ensuring there are no latent liabilities that could disrupt operations post-close. Tools such as a confidential information memorandum analyzer can help buyers quickly surface IP-related disclosures buried in dense transaction documents.

Sellers, for their part, benefit from organizing and documenting their IP portfolio well in advance of a process. A clean IP schedule — with verified ownership, current registrations, and no undisclosed third-party claims — is a meaningful signal of management quality and reduces buyer risk adjustments during negotiation. If you’re preparing your business for a transaction, start the preparation process early to give IP counsel sufficient runway.

Frequently Asked Questions

How is intellectual property typically valued in an M&A transaction?

IP is generally valued using one of three approaches: the income approach (discounting expected royalty streams or cost savings attributable to the IP), the market approach (benchmarking against comparable license transactions), or the cost approach (estimating the investment required to recreate the IP). In practice, sophisticated buyers use all three methods as cross-checks, with the income approach usually dominating for commercially active IP.

Can IP ownership issues kill a deal after a letter of intent is signed?

Yes. If diligence uncovers that a key patent is subject to an invalidity challenge, that source code was contributed by a developer who never signed an IP assignment agreement, or that a trademark is being contested in a key market, buyers may re-trade on price, require escrow arrangements, or walk away entirely. These are among the most common post-LOI renegotiation triggers in technology-sector transactions.

What is the difference between an asset sale and a stock sale when it comes to IP?

In an asset sale, IP assets are individually transferred and must be re-registered in the buyer’s name — a process that can take months and requires coordination with patent and trademark offices. In a stock sale, the entity holding the IP changes ownership without a direct transfer of the underlying registrations, which is simpler operationally but passes all historical liabilities to the buyer. The choice between structures has meaningful IP implications that counsel on both sides will negotiate carefully.

What role do non-compete and non-solicitation agreements play in protecting IP post-acquisition?

These agreements are often the last line of defense for acquired IP, particularly trade secrets tied to the departing founders or key technical employees. A patent can be enforced in court, but a proprietary process that lives only in a senior engineer’s head is protected primarily through contractual restrictions. Buyers acquiring IP-heavy companies should ensure that well-crafted non-compete and confidentiality agreements are part of the employment packages offered to key retained personnel.